Related references
Note: Only part of the references are listed.Safety and efficacy of long-term treatment of chronic/persistent ITP with eltrombopag: final results of the EXTEND study
Raymond S. M. Wong et al.
BLOOD (2017)
Efficacy and safety of thrombopoietin receptor agonists in patients with primary immune thrombocytopenia: A systematic review and meta-analysis
Li Wang et al.
SCIENTIFIC REPORTS (2016)
A randomized trial of avatrombopag, an investigational thrombopoietin-receptor agonist, in persistent and chronic immune thrombocytopenia
James B. Bussel et al.
BLOOD (2014)
Phase II study of avatrombopag in thrombocytopenic patients with cirrhosis undergoing an elective procedure
Norah A. Terrault et al.
JOURNAL OF HEPATOLOGY (2014)
Fibroproliferative activity in patients with immune thrombocytopenia (ITP) treated with thrombopoietic agents
Waleed Ghanima et al.
BRITISH JOURNAL OF HAEMATOLOGY (2011)
Eltrombopag for management of chronic immune thrombocytopenia (RAISE): a 6-month, randomised, phase 3 study
Gregory Cheng et al.
LANCET (2011)
International consensus report on the investigation and management of primary immune thrombocytopenia
Drew Provan et al.
BLOOD (2010)
Romiplostim or Standard of Care in Patients with Immune Thrombocytopenia.
David J. Kuter et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Safety and efficacy of long-term treatment with romiplostim in thrombocytopenic patients with chronic ITP
James B. Bussel et al.
BLOOD (2009)
Standardization of terminology, definitions and outcome criteria in immune thrombocytopenic purpura of adults and children: report from an international working group
Francesco Rodeghiero et al.
BLOOD (2009)
Evaluation of bone marrow reticulin formation in chronic immune thrombocytopenia patients treated with romiplostim
David J. Kuter et al.
BLOOD (2009)
AKR-501 (YM477) a novel orally-active thrombopoietin receptor agonist
Mari Fukushima-Shintani et al.
EUROPEAN JOURNAL OF HAEMATOLOGY (2009)
AKR-501 (YM477) in combination with thrombopoietin enhances human megakaryocytopoiesis
Mari Fukushima-Shintani et al.
EXPERIMENTAL HEMATOLOGY (2008)
Efficacy of romiplostim in patients with chronic immune thrombocytopenic purpura:: a double-blind randomised controlled trial
David J. Kuter et al.
LANCET (2008)
Eltrombopag for the treatment of chronic idiopathic thrombocytopenic purpura
James B. Bussel et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Phase 1 clinical study of eltrombopag, an oral, nonpeptide thrombopoietin receptor agonist
Julian M. Jenkins et al.
BLOOD (2007)
Pharmacodynamics and pharmacokinetics of AMG 531, a novel thrombopoietin receptor ligand
B Wang et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2004)
Share Paper
